BioSpace News Archive

Physicians can possibly use immunotherapy in cancer patients more effectively. More and more voices are in favor of giving this new treatment before the surgeon removes a tumor instead of afterwards. This could have huge benefits, like a better immune response against the tumor. On 22 October, researcher Christian Blank and his colleagues at the Netherlands Cancer Institute presented the results of a new study among melanoma patients at the ESMO conference.

The biocluster located in the Greater Paris region is the first European park to receive the Association of University Research Parks (AURP) award

Increasing achievement of FSGS partial remission of proteinuria and stable eGFR observed out to 84 weeks in open-label extension

Dubai South has signed a Memorandum of Understanding (MOU) with the UAE Ministry of Health and Prevention (MOHAP) as part of its efforts to strengthen cooperation with the pharmaceutical sector and enable pharmaceutical companies to take advantage of the opportunities to operate within Dubai South.

Study Met Safety and Tolerability Endpoints in 52-Week Study

Three- and four-year data continued to show reduction in amyloid plaque and to suggest a slowing of the rate of clinical decline in patients.

New research is shedding some light on how the brain responds when people are feeling sad, which could lead to new methods of treating some mood disorders. A research team from the University of California, San Francisco (UCSF) reported in an article in Cell that a network defined by amygdala-hippocampus β-coherence predicts mood in 13 of 21 subjects.

AcelRx is seeking $40 million to support the launch of Dsuvia and Sarepta eyes $500 million to support clinical research.

The Food and Drug Administration is taking care of a few approvals and committee meetings ahead of the Thanksgiving holiday week. They include drugs for COPD, a pain drug, and a sublingual film formulation of a well-known drug for erectile dysfunction. Here’s a look.

Progress in Q3 2018